Community Bank N.A. decreased its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 53,747 shares of the company’s stock after selling 632 shares during the period. Procter & Gamble makes up about 1.2% of Community Bank N.A.’s investment portfolio, making the stock its 17th largest position. Community Bank N.A.’s holdings in Procter & Gamble were worth $9,309,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Boston Partners boosted its position in shares of Procter & Gamble by 2.8% during the first quarter. Boston Partners now owns 33,483 shares of the company’s stock valued at $5,433,000 after buying an additional 902 shares during the period. Eastover Investment Advisors LLC increased its stake in Procter & Gamble by 0.9% in the second quarter. Eastover Investment Advisors LLC now owns 42,572 shares of the company’s stock worth $6,978,000 after purchasing an additional 395 shares during the period. Olistico Wealth LLC lifted its position in shares of Procter & Gamble by 5.9% during the second quarter. Olistico Wealth LLC now owns 3,575 shares of the company’s stock worth $590,000 after purchasing an additional 200 shares during the last quarter. Kingswood Wealth Advisors LLC boosted its stake in shares of Procter & Gamble by 30.8% during the second quarter. Kingswood Wealth Advisors LLC now owns 25,345 shares of the company’s stock valued at $4,180,000 after purchasing an additional 5,962 shares during the period. Finally, Astoria Portfolio Advisors LLC. grew its holdings in shares of Procter & Gamble by 4.6% in the second quarter. Astoria Portfolio Advisors LLC. now owns 6,917 shares of the company’s stock worth $1,141,000 after purchasing an additional 307 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on PG shares. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their target price for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. Evercore ISI upped their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Wells Fargo & Company raised their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday, November 22nd. Finally, Morgan Stanley increased their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Procter & Gamble Price Performance
Shares of Procter & Gamble stock opened at $179.26 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The business has a 50 day simple moving average of $170.48 and a two-hundred day simple moving average of $169.11. The stock has a market capitalization of $422.16 billion, a P/E ratio of 30.91, a PEG ratio of 3.86 and a beta of 0.42. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $180.43.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.83 EPS. As a group, analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.25%. Procter & Gamble’s payout ratio is 69.48%.
Insiders Place Their Bets
In other news, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 35,233 shares of company stock valued at $6,024,234 in the last ninety days. 0.18% of the stock is currently owned by corporate insiders.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Conference Calls and Individual Investors
- 3 Green Hydrogen Stocks That May Survive the Trump Chopping Block
- P/E Ratio Calculation: How to Assess Stocks
- Palo Alto Networks: A Pre-Split Investment Opportunity?
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Growth Stocks That Won’t Slow Down in 2025
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.